424,091
Participants
Start Date
January 1, 2017
Primary Completion Date
September 1, 2020
Study Completion Date
November 30, 2020
Research Site, Wilmington
Research Site, Washington D.C.
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY